-
1دورية أكاديمية
المؤلفون: Stelwagen, Johannes, Lubberts, Sjoukje, Steggink, Lars C., Steursma, Gerrie, Kruyt, Lara M., Donkerbroek, Jan Willem, van Roon, Arie M., van Gessel, Anne I., van de Zande, Saskia C., Meijer, Coby, Gräfin zu Eulenburg, Christine H., Oosting, Sjoukje F., Nuver, Janine, Walenkamp, Annemiek M. E., Jan de Jong, Igle, Lefrandt, Joop D., Gietema, Jourik A.Aff1
المصدر: British Journal of Cancer. 123(11):1599-1607
-
2دورية أكاديمية
المؤلفون: Nuver J; Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands., Smit AJ, van der Meer J, van den Berg MP, van der Graaf WT, Meinardi MT, Sleijfer DT, Hoekstra HJ, van Gessel AI, van Roon AM, Gietema JA
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Dec 20; Vol. 23 (36), pp. 9130-7. Date of Electronic Publication: 2005 Nov 21.
نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Cardiovascular Diseases/*chemically induced , Testicular Neoplasms/*drug therapy, Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers/blood ; Bleomycin/administration & dosage ; Bleomycin/adverse effects ; Carotid Arteries/drug effects ; Carotid Arteries/pathology ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Tunica Intima/drug effects ; Tunica Intima/pathology ; von Willebrand Factor/analysis
SCR Protocol: BEP protocol